Skip to content

Clinical trials

Connective Tissue Diseases trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Connective Tissue Diseases Country / region: Japan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20161
20182
20211
20223
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Completed4
Recruiting3
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Eli Lilly and Company2
GlaxoSmithKline2
Viatris Innovation GmbH2
AstraZeneca1
Beeline Medicines Corporation1
Biogen1
Chiesi Farmaceutici S.p.A.1
Keio University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Connective Tissue Diseases13
Autoimmune Diseases7
Immune System Diseases7
Lupus Erythematosus, Systemic6
Arthritis, Rheumatoid3
Lung Diseases, Interstitial3
Rheumatic Diseases2
Scleroderma, Diffuse2
Arthritis1
Collagen Diseases1

Trials

Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.